AMGEN UK HOLDINGS LIMITED
Opportunity 76/100 (strong), bankability 65/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (73/100).
Data confidence
Overall: medium (56/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Recent activity
- • 2 officers
- • 2 officers
- • 3 officers
- • 2 resolution
- • 2 capital
Corporate timeline (13 events)Click to expand
- 2026-07-06📄termination-director-company-with-name-termination-dateofficers · TM01
- 2026-07-03➖WALKER, Christopher Paul resigneddirector
- 2026-06-19📄appoint-person-director-company-with-name-dateofficers · AP01
- 2026-06-08➕PATEL, Binakumari Sanjay appointeddirector
- 2026-02-06📄resolutionresolution · RESOLUTIONS
- 2026-01-29📄capital-allotment-sharescapital · SH01
- 2026-01-28📄appoint-person-director-company-with-name-dateofficers · AP01
- 2026-01-22📄resolutionresolution · RESOLUTIONS
- 2026-01-15📄capital-allotment-sharescapital · SH01
- 2025-12-30➕ABBERLEY, Russell James appointeddirector
- 2025-12-08🏢Company incorporatedAs AMGEN UK HOLDINGS LIMITED
- 2025-12-08➕WALKER, Christopher Paul appointeddirector
- 2025-12-08📄incorporation-companyincorporation · NEWINC
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
- +Senior director age: Director aged approximately 60 — approaching natural succession window.
- +Young company: Only 0.6 years old — management layer unlikely to be developed.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- secondaryFounder aged 58+: Senior director is approximately 60. Early succession window.
- secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
Red flags
cleanGroup structure
Amgen Inc. is the ultimate parent — holding 75%+ shares. This company sits inside their group.
Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).
Shareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Amgen Inc. Corporate entity | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 08/12/2025 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Professional services · CB postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| ALPHUBEL LTD→ 12541436 · est 2020 · no financials extracted | — | — | — | — | 6y | — | — |
| ALVEIRE GROUP LIMITED→ 15633681 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| ALWAYS FIRE SAFETY LTD→ 13866022 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| AMAREW LIMITED→ 12125934 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| AMAVANTI LIMITED→ 10176461 · est 2016 · no financials extracted | — | — | — | — | 9y | — | — |
| AMAZING GRAZING FOODS LTD→ 08463456 · est 2013 · no financials extracted | — | — | — | — | 13y | — | — |
| AMBERDEN ASSOCIATES LTD→ 13813377 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| AMBROSE HEALTHCARE (HOLDINGS) LTD→ 15324624 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AMBROSE HEALTHCARE LTD→ 14409383 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| AMG COMPOSITE TECHNOLOGIES LTD→ 11976184 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| AMK BIOCONSULTING LTD→ 17091100 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| AMORPHIQ LTD→ 16569380 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (2 active · 1 resigned)
Click a director name to see their full track record across all companies.